These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21715130)

  • 1. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimycobacterial activity of fluorenizid salts].
    Zarichna OZ
    Mikrobiol Z; 2007; 69(5):65-9. PubMed ID: 18217356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the design and synthesis of heterocycles as anti-tubercular agents.
    Chauhan PM; Sunduru N; Sharma M
    Future Med Chem; 2010 Sep; 2(9):1469-500. PubMed ID: 21426140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
    Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
    Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitubercular potential of plants: a brief account of some important molecules.
    Negi AS; Kumar JK; Luqman S; Saikia D; Khanuja SP
    Med Res Rev; 2010 Jul; 30(4):603-45. PubMed ID: 19626592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.
    Nefzi A; Appel J; Arutyunyan S; Houghten RA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antitubercular activity of diarylmethylnaphthol derivatives.
    Das SK; Panda G; Chaturvedi V; Manju YS; Gaikwad AK; Sinha S
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5586-9. PubMed ID: 17764933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
    Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
    Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitubercular drug development: current status and research strategies.
    Barot KP; Nikolova S; Ivanov I; Ghate MD
    Mini Rev Med Chem; 2013 Oct; 13(11):1664-84. PubMed ID: 23895192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
    Patel KN; Telvekar VN
    Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.